Cancer and venous thromboembolism: An old association with new scenarios;Cáncer y tromboembolia venosa: una antigua asociación con nuevos escenarios

Medicina Clinica

Volumn 133, Issue 14, 2009, Pages 545-546

  Lecumberri, Ramón ^a   Rocha, Eduardo ^b  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT THERAPY; ARTICLE; CANCER PATIENT; CARDIOVASCULAR RISK; CHEMOPROPHYLAXIS; DISEASE ASSOCIATION; HOSPITALIZATION; IMMOBILIZATION; NEOPLASM; VENOUS THROMBOEMBOLISM;

HUMANS; NEOPLASMS; VENOUS THROMBOEMBOLISM;

EID: 70349767942     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2009.06.019     Document Type: Article

References (16)

1. Trousseau A. Phlegmasia alba dolens. In: Trousseau A. (Ed). Clinique medicale de l'Hotel-Dieu de Paris (1865), Baillière, Paris 654-712
2. Varki A. Trousseaus's syndrome: Multiple definitions and multiple mechanisms. Blood 110 (2007) 1723-1729
3. Rickles F.R., Patierno S., and Fernández P.M. Tissue factor, thrombin and cancer. Chest 124 (2003) 58S-68S
4. Lecumberri R., Feliu J., and Rocha E. Tromboembolia venosa en pacientes con cáncer. Med Clin (Barc) 127 (2006) 22-32
5. Lyman G.H., Khorana A.A., Falanga A., Clarke-Pearson D., Flowers C., Jahanzeb M., et al. American Society of Clinical Oncology Guideline: Recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. J Clin Oncol 25 (2007) 5490-5505
6. Khorana A.A., Kuderer N.M., Culakova E., Lyman G.H., and Francis C.V. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 111 (2008) 4902-4907
7. Rasmussen M.S. Does prolonged thromboprophylaxis improve outcome in patients undergoing surgery?. Cancer Treat Review 29 (2003) 15-17
8. Monreal M., Falgá C., Valdés M., Suárez C., Gabriel F., Tolosa C., et al., RIETE investigators. Fatal pulmonary embolism and fatal bleeding in cancer patients with venous thromboembolism: Findings from the RIETE Registry. J Thromb Haemost 4 (2006) 1950-1956
9. Sorensen H.T., Mellemkjaer L., Olsen J.H., and Baron J.A. Prognosis of cancer associated with venous thromboembolism. N Engl J Med 343 (2000) 1846-1850
10. Kearon C., Kahn S., Agnelli G., Goldhaber S., Raskob G.E., and Comerota A.J. Antithrombotic therapy for venous thromboembolic disease. American Colege of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 133 (2008) 454S-545S
11. Carrier M., Le Gal G., Cho R., Tierney S., Rodger M., and Lee A.Y. Dose escalation of low molecular weight heparin to manage recurrent venous thromboembolic events despite systemic anticoagulation in cancer patients. J Thromb Haemost 7 (2009) 760-765
12. Lecumberri R., Páramo J.A., and Rocha E. Anticoagulant treatment and survival in cancer patients. The evidence from clinical studies. Haematologica 90 (2005) 1258-1266
13. Douketis J.D., Gu C., Piccioli A., Ghirarduzzi A., Pengo V., and Prandoni P. The long-term risk of cancer in patients with a first episode of venous thromboembolism. J Thromb Haemost 7 (2009) 546-551
14. Carrier M., Le Gal G., Wells P.S., Fergusson D., and Rodger M.A. Systematic review: The Trousseau syndrome revisited: Should we screen extensively for cancer in patients with venous thromboembolism?. Ann Intern Med 149 (2008) 323-333
15. Blanch M, Calvo M, Romera A, Pérez-Piqueras A, Riera S, Cairols MA. ¿Es la trombosis venosa profunda un marcador de recidiva de una neoplasia? Med Clin (Barc). 2009. 10.1016/j.medcli.2009.04.054
16. Lecumberri R., Marqués M., Díaz-Navarlaz M.T., Panizo E., Toledo J., García-Mouriz A., et al. Maintained effectiveness of an electronic alert system to prevent venous thromboembolism among hospitalized patients. Thromb Haemost 100 (2008) 699-704